Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teleflex, ResMed in NIV mask partnership

This article was originally published in Clinica

Executive Summary

Teleflex Medical has become the exclusive distributor of ResMed’s non-invasive ventilation (NIV) mask portfolio in the US. The deal will see Teleflex make the masks available to all acute care hospitals not affiliated with the Veterans Administration. Teleflex (Research Triangle Park, North Carolina) already markets a range of NIV-based products such as vented and non-vented masks, breathing circuits and humidification technology. According to Teleflex, the market for NIV products is expected to continue growing as more healthcare facilities adopt practices aimed at reducing ventilator-associated pneumonia, the second most common hospital associated infection. NIV is proven to improve oxygenation and is well tolerated by acute respiratory failure patients, said the company. Financial terms of the deal were not disclosed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043209

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel